Uterine Sarcomas (Ongoing)

Posted On 2020-08-31 11:02:00



This special series on “Uterine Sarcomas” is co-edited by Dr. Anna Myriam Perrone and Dr. Pierandrea De Iaco, from S.Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.

Anna Myriam Perrone
Oncologic Gynaecology Unit, Department Medical and Surgical Sciences (DIMEC), S. Orsola Hospital, University of Bologna, Bologna, Italy

Dr. Perrone is a Senior Assistant in Department of Gynecologic Oncology at Sant’ Orsola Hospital, Bologna, Italy and also is a Member of the Multicenter Italian Trials in Ovarian Cancer and gynecologic malignancies (MITO) group.

Dr. Perrone’ area of interest including Treatment of Gynaecologic Malignancies (cervical, endometrial, ovarian and vulvar cancer), Minimally invasive surgery in gynaecologic cancers (Laparoscopy and Robotic), Sentinel node procedures, Fertility preservation in gynaecologic cancers, Rare gynaecological diseases (sarcomas and granulosa ovarian tumors), Electrochemotherapy in vulvar and vaginal cancers, Intraoperative chemotherapy in ovarian cancers (HIPEC and PIPAC), preservation of quality of life and sexual activity after oncological treatments (Laser therapy).

Pierandrea De Iaco
Gynecologic Oncology Unit, S. Orsola Malpighi Hospital, Bologna University, Bologna, Italy

Pierandrea De Iaco is Associate Professor of Obstetrics and Gynecology at the University of Bologna. He graduated in Medicine and specialized in Obstetrics and Gynecology, General Surgery and Urology at the University of Bologna. He taught "Gynaecologic Oncology and surgical techniques" at the medical School and postgraduate school of Gynecology and Obstetrics, Radiotherapy and Radiology of Bologna. Prof. P. De Iaco organized many workshops about Surgical Techniques and surgical complication in laparotomic and minimally invasive surgery in Ginecologic Oncology at the Policlinico S. Orsola. Member of the Multicenter Italian Trials in Ovarian Cancer and gynecologic malignancies (MITO) group.

Area of interest are: Treatment of Gynaecologic Malignancies (cervical, endometrial, ovarian and vulvar cancer), Minimally invasive surgery in gynaecologic cancers (Laparoscopy and Robotic), Sentinel node procedures, Fertility preservation in gynaecologic cancers, Rare gynaecological diseases (sarcomas and granulosa ovarian tumors), Electrochemotherapy in vulvar and vaginal cancers, Intraoperative chemotherapy in ovarian cancers (HIPEC and PIPAC), preservation of quality of life and sexual activity after oncological treatments (Laser therapy).

Series outline:

  1. Sonographic imaging in uterine sarcomas
  2. Indication to radiotherapy in uterine sarcomas
  3. Indication to chemotherapy in uterine sarcomas
  4. Nuclear medicine in uterine sarcomas
  5. Fertility sparing in uterine sarcomas
  6. Role of surgery in early stages uterine sarcomas
  7. Role of surgery in advanced stages uterine sarcomas
  8. Pathological analysis in uterine sarcomas
  9. Forensis aspects of sarcomas morcellation
  10. Risk of minivasive surgery in uterine sarcomas
Disclosure: 
The series “Uterine Sarcomas” was commissioned by the editorial office, Gynecology and Pelvic Medicine without any sponsorship or funding. Anna Myriam Perrone and Pierandrea De Iaco are serving as the unpaid Guest Editors for the series.